SK7652002A3 - Crystalline form of (s)-2-ethoxy-3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid - Google Patents

Crystalline form of (s)-2-ethoxy-3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid Download PDF

Info

Publication number
SK7652002A3
SK7652002A3 SK765-2002A SK7652002A SK7652002A3 SK 7652002 A3 SK7652002 A3 SK 7652002A3 SK 7652002 A SK7652002 A SK 7652002A SK 7652002 A3 SK7652002 A3 SK 7652002A3
Authority
SK
Slovakia
Prior art keywords
crystalline form
compound
ethoxy
formula
solution
Prior art date
Application number
SK765-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Maria Boije
Karol Horvath
Tord Inghardt
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9904416A external-priority patent/SE9904416D0/xx
Priority claimed from SE0001187A external-priority patent/SE0001187D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK7652002A3 publication Critical patent/SK7652002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
SK765-2002A 1999-12-03 2000-11-29 Crystalline form of (s)-2-ethoxy-3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid SK7652002A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904416A SE9904416D0 (sv) 1999-12-03 1999-12-03 Crystalline form
SE0001187A SE0001187D0 (sv) 2000-04-03 2000-04-03 Crystalline form
PCT/SE2000/002384 WO2001040171A1 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid

Publications (1)

Publication Number Publication Date
SK7652002A3 true SK7652002A3 (en) 2002-11-06

Family

ID=26655058

Family Applications (1)

Application Number Title Priority Date Filing Date
SK765-2002A SK7652002A3 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2-ethoxy-3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid

Country Status (30)

Country Link
US (1) US6531622B1 (de)
EP (1) EP1237855B1 (de)
JP (1) JP2003515582A (de)
KR (1) KR20030029040A (de)
CN (1) CN1198799C (de)
AR (1) AR029412A1 (de)
AT (1) ATE261431T1 (de)
AU (1) AU773777B2 (de)
BR (1) BR0016131A (de)
CA (1) CA2392038A1 (de)
CO (1) CO5271735A1 (de)
CZ (1) CZ20021902A3 (de)
DE (1) DE60008921T2 (de)
DK (1) DK1237855T3 (de)
EE (1) EE200200278A (de)
ES (1) ES2215769T3 (de)
HK (1) HK1048980A1 (de)
HU (1) HUP0203444A3 (de)
IL (1) IL149577A0 (de)
IS (1) IS6400A (de)
MX (1) MXPA02005327A (de)
MY (1) MY135954A (de)
NO (1) NO20022598L (de)
NZ (1) NZ518925A (de)
PL (1) PL357118A1 (de)
PT (1) PT1237855E (de)
RU (1) RU2268880C2 (de)
SK (1) SK7652002A3 (de)
TR (1) TR200401333T4 (de)
WO (1) WO2001040171A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812772A (pt) 1997-10-27 2000-10-10 Reddy Research Foundation "compostos tricìclicos inéditos e o seu emprego na medicina;processo para a sua preparação e composições farmacêuticas contendo os mesmos"
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
CN1280574A (zh) 1997-10-27 2001-01-17 雷迪研究基金会 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
RU2247722C2 (ru) 1997-10-27 2005-03-10 Др. Редди`З Лабораториз Лимитед Производные арилкарбоновых кислот, способы их получения, фармацевтическая композиция на их основе, способы лечения и предупреждения различных заболеваний, промежуточные соединения и способы их получения
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
WO2000026200A1 (en) 1998-10-29 2000-05-11 Dr. Reddy's Research Foundation An improved process for the preparation of new antidiabetic agents
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
US7084177B2 (en) * 1999-12-03 2006-08-01 Astrazeneca Ab Comminuted form of(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
WO2005051298A2 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
EP1586573B1 (de) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
DE102004035034A1 (de) * 2004-07-20 2006-02-16 Degussa Ag Racematspaltung von p-Hydroxyphenyl-2-alkoxy-propionsäuren
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues

Also Published As

Publication number Publication date
DE60008921T2 (de) 2005-01-20
ATE261431T1 (de) 2004-03-15
TR200401333T4 (tr) 2004-08-23
RU2002113450A (ru) 2004-01-10
AU773777B2 (en) 2004-06-03
IL149577A0 (en) 2002-11-10
CN1409701A (zh) 2003-04-09
BR0016131A (pt) 2002-08-20
EE200200278A (et) 2003-06-16
MXPA02005327A (es) 2002-12-06
EP1237855B1 (de) 2004-03-10
PT1237855E (pt) 2004-06-30
WO2001040171A1 (en) 2001-06-07
MY135954A (en) 2008-07-31
US6531622B1 (en) 2003-03-11
AU2035001A (en) 2001-06-12
PL357118A1 (en) 2004-07-12
DE60008921D1 (en) 2004-04-15
NZ518925A (en) 2004-06-25
HUP0203444A3 (en) 2003-05-28
ES2215769T3 (es) 2004-10-16
AR029412A1 (es) 2003-06-25
CZ20021902A3 (cs) 2002-11-13
HK1048980A1 (en) 2003-04-25
NO20022598D0 (no) 2002-05-31
RU2268880C2 (ru) 2006-01-27
EP1237855A1 (de) 2002-09-11
CA2392038A1 (en) 2001-06-07
DK1237855T3 (da) 2004-06-14
CO5271735A1 (es) 2003-04-30
JP2003515582A (ja) 2003-05-07
HUP0203444A2 (hu) 2003-02-28
KR20030029040A (ko) 2003-04-11
IS6400A (is) 2002-05-28
CN1198799C (zh) 2005-04-27
NO20022598L (no) 2002-05-31

Similar Documents

Publication Publication Date Title
SK7652002A3 (en) Crystalline form of (s)-2-ethoxy-3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
JP3493341B2 (ja) ＥｔＯ２Ｃ−ＣＨ２−（Ｒ）Ｃｇｌ−Ａｚｅ−Ｐａｂ−ＯＨの結晶形
TWI450896B (zh) 反式－４－〔〔（５ｓ）－５－〔〔〔３，５－雙（三氟甲基）苯基〕甲基〕（２－甲基－２ｈ－四唑－５－基）胺基〕－２，３，４，５－四氫－７，９－二甲基－１ｈ－１－苯并氮呯－１－基〕甲基〕－環己基羧酸
JP2001513767A (ja) メタロプロテアーゼ阻害剤としての逆ヒドロキサメート誘導体
JP2019523273A (ja) ベリノスタットの多形形態、およびその調製のためのプロセス
JP4541140B2 (ja) 新塩類
US5063246A (en) Phenethylamine derivative compositions and use
WO2001040165A1 (en) Crystalline form of 3-{4-[2-(4-tert-butoxycarbonylaminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid
KR20060120648A (ko) 기질 금속단백분해효소 억제제
RU2481341C2 (ru) Кристаллические модификации 3-(1н-индол-3-ил)-4-[2-(4-метилпиперазин-1-ил)хиназолин-4-ил]пиррол-2,5-диона
US20230167132A1 (en) Forms and compositions of inhibitors of plasma kallikrein
GB2171997A (en) 4-Amino-6,7-dimethoxy-2-Piperazin-1-ylquinazoline derivatives
US20100222394A1 (en) Method for producing pyrazol-3-yl-benzamide derivative
US6306886B1 (en) Crystalline roxifiban
SK1182000A3 (en) 2-{3-[4-(2-T-BUTYL-6-TRIFLUOROMETHYLPYRIDIN-4-YL)-PIPERAZIN-ì (54) -1-YL]PROPYLMERCAPTO} PYRIMIDIN-4-OL-FUMARATE
ZA200203706B (en) Crystalline form of (S)-2ethoxy-3-[4-(2-4-methanesulfonyloxyphenyl} ethoxy)phenyl] propanoic acid.
WO2019015640A1 (zh) 一种氮杂环酰胺衍生物的盐、其晶型及其制备方法和用途
WO2011158262A1 (en) Polymorphic form of fexofenadine hydrochloride, intermediates and process for its preparation
EP3960742A1 (de) Kristalle von alkinyl-enthaltenden verbindungen, salz und solvat davon, herstellungsverfahren und anwendungen
KR20060011997A (ko) 벤즈이미다졸 유도체의 결정 및 이의 제조 방법
WO2021211938A1 (en) Solid forms of inhibitors of plasma kallikrein
CZ163693A3 (en) Novel isobutyl substituted amides of methanesulfonyl-quinolylmethoxyphenyl-cycloalkylacetic acid
AU2001100436A4 (en) Amlodipine hemimaleate
JPH08109183A (ja) 二環式オキサゾールおよびチアゾール置換エーテル
WO2007088063A1 (en) Acid addition salts of n-{3-[4-(2-methoxyphenyl)-l-piperazinyl]-propyl}-7-oxo-5- trifluoromethyl-7h-thieno[3,2-b]pyran-3-carboxamide